Effect of magnesium sulphate in experimental spinal cord injury: Evaluation with ultrastructural findings and early clinical results

Journal of Clinical Neuroscience

Volumn 10, Issue 3, 2003, Pages 329-334

  Kaptanoglu, Erkan ^a   Beskonakli, Etem ^a,c   Okutan, Ozerk ^a   Surucu, H Selcuk ^b   Taskin, Yamac ^a  

^a Research Hospital   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Excitotoxicity; Magnesium; Neuroprotection; Scoring; Spinal cord injury; Ultrastructure

Indexed keywords

MAGNESIUM SULFATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; NEUROLOGIC EXAMINATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SCORING SYSTEM; SPINAL CORD; SPINAL CORD INJURY; ULTRASTRUCTURE;

EID: 0038509943     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0967-5868(03)00031-6     Document Type: Article

References (47)

1. Anderson DK, Demediuk P, Saunders RD, Dugan LL, Means ED, Horrocks LA. Spinal cord injury and protection. Ann Emerg Med 1985; 14: 816-821.
2. Anderson DK, Means ED, Waters T, Spears CJ. Spinal cord energy metabolism following compression trauma to the feline spinal cord. J Neurosurg 1980; 53: 375-380.
3. Anderson DK, Hall ED. Pathophysiology of spinal cord trauma. Ann Emerg Med 1993; 22: 987-992.
4. Dumont RJ, Verma S, Okonkwo DO et al. Acute spinal cord injury, part II: contemporary pharmacotherapy. Clin Neuropharmacol 2001; 24: 265-279.
5. Faden AI. Therapeutic approaches to spinal cord injury. Adv Neurol 1993; 72: 377-386.
6. Hall ED, Wolf DL. A pharmacological analysis of the pathophysiological mechanisms of posttraumatic spinal cord ischemia. J Neurosurg 1986; 64: 951-961.
7. Tator CH. Update on the pathophysiology and pathology of acute spinal cord injury. Brain Pathol 1995; 5: 407-413.
8. Tator CH, Fehlings MG. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 1991; 75: 15-26.
9. Dumont RJ, Okonkwo DO, Verma S et al. Acute spinal cord injury, part I: pathophysiologic mechanisms. Clin Neuropharmacol 2001; 24: 254-264.
10. Kaptanoglu E, Caner HH, Surucu HS, Akbiyik F. Effect of mexiletine on lipid peroxidation and early ultrastructural findings in experimental spinal cord injury. J Neurosurg (Spine 2) 1999; 91: 200-204.
11. Kaptanoglu E, Sen S, Beskonakh E et al. Antioxidant actions and early ultrastructural findings of thiopental and propofol in experimental spinal cord injury. J Neurosurg Anesthesiol 2002; 14: 114-122.
12. Kaptanoglu E, Tuncel M, Pataoglu S, Konan A, Demirpence E, Kilinc K. Comparison of the effects of melatonin and methylprednisolone in experimental spinal cord injury. J Neurosurg (Spine 1) 2000; 93: 77-84.
13. Faden AI, Simon RP. A potential role for excitotoxins in the pathophysiology of spinal cord injury. Ann Neurol 1988; 23: 623-626.
14. Li S, Stys PK. Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter. J Neurosci 2000; 20: 1190-1198.
15. Gomez-Pinilla F, Tram H, Cotman CW, Nieto-Sampedro M. Neuroprotective effect of MK-801 and U-50488H after contusive spinal cord injury. Exp Neurol 1989; 104: 118-124.
16. Li S, Tator CH. Action of locally administrated NMDA and AMPA/kainate rcceptor antagonists in spinal cord injury. Neurol Res 2000; 22: 171-180.
17. Liu D, Thangnipon W, McAdoo DJ. Excitatory amino acids rise toxic levels upon impact injury to the rat spinal cord. Brain Res 1991; 547: 344-348.
18. Mu X, Azbill RD, Springer JE. Riluzole and methylprednisolone combined treatment improves functional recovery in traumatic spinal cord injury. J Neurotrauma 2000; 17: 773-780.
19. Muir KW, Less KR. A randomized, double blind, placebo controlled pilot trial of intravenous magnesium sulphate in acute stroke. Stroke 1995; 26: 1183-1188.
20. Wolf G, Fischcr S, Abicht K, Keilhoff G. Magnesium sulphate subcutaneously injected protects against kainate-induced convulsions and neurodegeneration: in vivo study on the rat hippocampus. Neuroscience 1991; 43: 31-34.
21. Heath DL, Vink R. Optimization of magnesium therapy after severe diffuse axonal injury in rats. J Pharmacol Exp Ther 1999; 288: 1311-1316.
22. Ustun ME, Gurbilek M, Ak A, Vatansev H, Duman A. Effects of magnesium sulphate on tissue lactate and malondialdehyde levels in experimental head trauma. Intensive Care Med 2001; 27: 264-268.
23. Land-Lazdunski L, Heurteaux C, Dupont H, Widmann C, Lazdunski M. Prevention of ischemic spinal cord injury: comparative effects of magnesium sulphate and riluzole. J Vasc Surg 2000; 32: 179-189.
24. Robertson CS, Foltz R, Grossman G, Goodman JC. Protection against experimental ischemic spinal cord injury. J Neurosurg 1986; 64: 633-642.
25. Simpson JA, Eide TR, Schiff GA et al. Intrathecal magnesium sulphate protects the spinal cord from ischemic injury during aortic cross-clamping. Anesthesiology 1994; 81: 1493-1499.
26. Suzer T, Coskun E, Islekel H, Tahta K. Neuroprotective effect of magnesium on lipid peroxidation and axonal function after experimental spinal cord injury. Spinal Cord 1999; 37: 480-484.
27. Allen AR. Surgery of experimental lesion of spinal cord equivalent to crush injury of fracture dislocation of spinal column. A preliminary report. JAMA 1911; 57: 878-880.
28. Kirkali Z, Esen AA, Hayran M et al. The effect of extracorporeal electromagnetic shock waves on the morphology and contractility of rabbit ureter. J Urol 1995; 154: 1939-1943.
29. Tasdemir O, Katircioglu F, Kucukaksu DS et al. Warm blood cardioplegia: ultrastructural and hemodynamic study. Ann Thorac Surg 1993; 56: 305-311.
30. Rivlin AS, Tator CH. Effect of duration of acute spinal cord compression in a new acute cord injury model in the rat. Surg Neurol 1978; 10: 39-43.
31. Basso DM, Beattie MS, Bresnahan JC. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol 1996; 139: 244-256.
32. Gale K, Keresidis H, Wrathall JR. Spinal cord contusion in the rat: behavioral analysis of functional neurologic impairment. Exp Neurol 1985; 88: 123-134.
33. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994; 330: 613-622.
34. 2+ of NMDA responses in spinal cord neurons. Nature (London) 1984; 309: 261-263.
35. Rothman SM. Synaptic activity mediates death of hypoxic neurons. Science 1983; 220: 536-537.
36. McIntosh TK, Vink R, Soares H, Hayes RL, Simon RP. Effect of noncompetitive blockage of N-methyl-D-aspartate receptors on the neurochemical sequel of experimental brain injury. J Neurochem 1990; 55: 1170-1179.
37. Gunther T, Hollriegl V, Vormann J, Bubeck J, Classen HG. Increased lipid peroxidation in rat tissues by magnesium deficiency and vitamin E depletion. Magnes Bull 1994; 16: 38-43.
38. Vink R, Golding EM, Headrick JP. Bioenergetic analysis of oxidative mechanism following traumatic brain injury in rats. J Neurotrauma 1994; 11: 265-274.
39. Nadler JL, Goodson S, Rude RK. Evidence that prostacyclin mediates the vascular action of magnesium in humans. Hypertension 1987; 9: 379-783.
40. Dickenss BF, Weglicki WB, Li YS, Mak IT. Magnesium deficiency in vitro enhances free radical induced intracellular oxidation and cytotoxicity in endothelial cells. FEBS Lett 1992; 311: 187-191.
41. Regan RF, Jasper E, Guo Y, Scott PS. The effect of magnesium on oxidative neuronal injury in vitro. J Neurochem 1998; 70: 77-85.
42. Ravn HB, Vissinger H, Kristensen SD, Wennmalm A, Tyhgesen K, Husted SE. Magnesium inhibits platelet activity - an infusion study in healthy volunteers. Thromb Haemost 1996; 75: 939-944.
43. Schwartz G, Fehlings MG. Evaluation of the neuroprotective effects of sodium channel blockers after spinal cord injury: improved behavioral and neuroanatomical recovery with riluzole. J Neurosurg (Spine 2) 2001; 94: 245-256.
44. Koroshetz WJ, Moskowitz MA. Emerging treatments for stroke in humans. Trends Pharmacol 1996; 17: 227-233.
45. Morris RGM, Anderson E, Lynch GS, Baudry M. Selective impairment of learning and blockage of long term potentiation by N-methyl-D-aspartate receptor antagonist, AP5. Nature 1986; 319: 774-776.
46. Olney JW, Labruyere J, Price MT. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 1989; 244: 1360-1362.
47. Sadeh M. Action of magnesium sulphate in the treatment of preeclampsia-eclampsia. Stroke 1989; 20: 1273-1275.